SIGA

Siga Technologie

4.425

+0.135+3.15%

Opening15:17 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.350/4.290

TODAY RANGE4.350-4.450

VOL199.37K

MARKET CAP317.38M

52 WEEK RANGE4.095-8.51

AVG VOL (3M)663.75K

% TURNOVER0.28%

TURNOVER--

P/E (TTM)15.71

% RANGE2.33%

EPS(TTM)0.2816

P/E(FORWARD)29.50

P/B2.093

BVPS2.114

DIVIDEND--

P/S3.350

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP181.97M

SHARES OUTSTANDING71.72M

NEXT EARNINGS08/03-08/07

FREE FLOAT41.12M

LOT SIZE1

EX-DATE04/07/2026

News

Press Releases

Financial Reports

Profile

TipRanks·05/20 03:34
Siga Technologies Balances Lumpy Results With Strong Cash
Seeking Alpha·05/08 10:42
SIGA expects Q2 delivery of approximately $13M of oral TPOXX while targeting an FDA PEP submission in the next 12 months
TipRanks·05/08 02:21
Siga Technologies Earnings Call: Cash-Rich, Orders Ahead
PUBT·05/07 22:40
SIGA publishes investor presentation on TPOXX smallpox antiviral franchise and growth strategy
Seeking Alpha·05/07 20:53
SIGA Technologies GAAP EPS of -$0.05, revenue of $6.2M
Reuters·05/07 20:43
SIGA Technologies Q1 revenue falls, net loss widens
Dow Jones·05/07 20:07
*SIGA Technologies 2Q Loss/Shr 5c >SIGA
Dow Jones·05/07 20:07
*SIGA Technologies 2Q Rev $6.24M >SIGA
Benzinga·05/07 20:02
SIGA Technologies Q1 EPS $(0.05) Down From $(0.01) YoY, Sales $6.243M Down From $7.041M YoY
Reuters·05/07 20:01
BRIEF-SIGA Technologies Q1 EPS USD -0.05
Dow Jones·05/07 20:01
Press Release: SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
Dow Jones·05/07 20:01
Press Release: SIGA Reports Financial Results for -2-
PUBT·04/30 11:30
SIGA Technologies to host business update call after first-quarter results
PUBT·04/28 20:03
SIGA Technologies announces annual shareholder meeting via webcast
Benzinga·04/07 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Same Industry

Name/Symbol

Change%

Price

SIGA

McKesson

MCK

+0.05%

735.17

BIIB

Amgen Inc

AMGN

-0.19%

328.51

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+8.50%

0.1098

Lilly Eli & Co

LLY

-1.93%

CELG

TXMD

JNJ

Abbvie Inc

ABBV

-0.42%

217.72

ZTS

GILD

Novo-Nordisk A/S

NVO

-2.61%

42.92

Bristol-Myers Squibb Co

BMY

-3.90%

54.95

ALXN

PFE

SNY

GCVRZ

NVS

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.